Global Markets
Home›Global Markets›North America›Head of Hong Kong’s new drug regulator pledges to buil…
Head of Hong Kong’s new drug regulator pledges to build trust, push innovation
The head of Hong Kong’s new drug regulatory body has pledged to build a fully capable and globally trusted agency that will become a catalyst for medical innovation rather than merely acting as a “miniature version” of existing overseas models. Dr Li Zili, controller of the Hong Kong Centre for Medical Products Regulation (CMPR), said that while many other places in Asia, such as mainland China, Singapore and Japan, had established regulatory agencies long ago, Hong Kong had a distinctive...
← Newer storySingapore’s toxic haze probe expands to 10 palm oil, forestry firmsOlder story →Hong Kong’s pursuit of top university rankings comes at a cost
More like this
Global MarketsHow Shimao’s sale of 2 hotels reveals the growing complexity of Hong Kong debt workouts
Global MarketsHow Hong Kong’s 5-year plan can fuel its financial clout